中国肿瘤临床
中國腫瘤臨床
중국종류림상
Chinese Journal of Clinical Oncology
2015年
16期
796-802
,共7页
李军%沈毅%吴逸群%竺涵光%张陈平%张志愿%孙坚
李軍%瀋毅%吳逸群%竺涵光%張陳平%張誌願%孫堅
리군%침의%오일군%축함광%장진평%장지원%손견
颅底%肿瘤%颅颌面切除术%适应证
顱底%腫瘤%顱頜麵切除術%適應證
로저%종류%로합면절제술%괄응증
skull base%tumor%cranio-maxillofacial resection%indication
目的:回顾性分析近10年颅颌面联合切除手术资料的基础上,探讨对该类手术适应证的选择.方法:2003年2月至2013年12月,上海交通大学医学院附属第九人民医院共行颅颌面联合切除术治疗累及颅底的肿瘤116例,根据CT及MRI冠状位所示的颅底受肿瘤侵犯情况分为3类,Ⅰ型为肿瘤紧邻颅底但尚未破坏颅底骨质(n=45)、Ⅱ型为肿瘤破坏颅底骨质但硬脑膜完整(n=30)、Ⅲ型为肿瘤侵犯硬脑膜但未侵犯脑实质(n=41).116例患者的肿瘤均行颅颌面联合切除手术,并根据缺损情况分别采用邻近局部或区域组织瓣(n=62)和游离血管化组织瓣(n=54)修复缺损.结果:所有患者均顺利完成颅颌面联合切除手术,未发生术中并发症.组织瓣转移成功率为98.3%,游离组织瓣转移成功率为96.4%.3例分别因术后颅内感染(n=2)和颈内动脉出血(n=1)死亡.围手术期的并发症率为14.7%,死亡率为2.6%.94例患者随访6月~11年,36例发现肿瘤复发或远处转移,总复发及转移率为38.5%.肿瘤复发转移所致的死亡率为17.7%,恶性肿瘤复发转移的死亡率为23.2%.结论:对于颅颌面联合切除术应严格把握其适应证,注意肿瘤根治和术后功能、生存率和生存质量之间的平衡,即注重功能和外形、生存率和生存质量、供区和受区、重要功能和次要功能之间的平衡.
目的:迴顧性分析近10年顱頜麵聯閤切除手術資料的基礎上,探討對該類手術適應證的選擇.方法:2003年2月至2013年12月,上海交通大學醫學院附屬第九人民醫院共行顱頜麵聯閤切除術治療纍及顱底的腫瘤116例,根據CT及MRI冠狀位所示的顱底受腫瘤侵犯情況分為3類,Ⅰ型為腫瘤緊鄰顱底但尚未破壞顱底骨質(n=45)、Ⅱ型為腫瘤破壞顱底骨質但硬腦膜完整(n=30)、Ⅲ型為腫瘤侵犯硬腦膜但未侵犯腦實質(n=41).116例患者的腫瘤均行顱頜麵聯閤切除手術,併根據缺損情況分彆採用鄰近跼部或區域組織瓣(n=62)和遊離血管化組織瓣(n=54)脩複缺損.結果:所有患者均順利完成顱頜麵聯閤切除手術,未髮生術中併髮癥.組織瓣轉移成功率為98.3%,遊離組織瓣轉移成功率為96.4%.3例分彆因術後顱內感染(n=2)和頸內動脈齣血(n=1)死亡.圍手術期的併髮癥率為14.7%,死亡率為2.6%.94例患者隨訪6月~11年,36例髮現腫瘤複髮或遠處轉移,總複髮及轉移率為38.5%.腫瘤複髮轉移所緻的死亡率為17.7%,噁性腫瘤複髮轉移的死亡率為23.2%.結論:對于顱頜麵聯閤切除術應嚴格把握其適應證,註意腫瘤根治和術後功能、生存率和生存質量之間的平衡,即註重功能和外形、生存率和生存質量、供區和受區、重要功能和次要功能之間的平衡.
목적:회고성분석근10년로합면연합절제수술자료적기출상,탐토대해류수술괄응증적선택.방법:2003년2월지2013년12월,상해교통대학의학원부속제구인민의원공행로합면연합절제술치료루급로저적종류116례,근거CT급MRI관상위소시적로저수종류침범정황분위3류,Ⅰ형위종류긴린로저단상미파배로저골질(n=45)、Ⅱ형위종류파배로저골질단경뇌막완정(n=30)、Ⅲ형위종류침범경뇌막단미침범뇌실질(n=41).116례환자적종류균행로합면연합절제수술,병근거결손정황분별채용린근국부혹구역조직판(n=62)화유리혈관화조직판(n=54)수복결손.결과:소유환자균순리완성로합면연합절제수술,미발생술중병발증.조직판전이성공솔위98.3%,유리조직판전이성공솔위96.4%.3례분별인술후로내감염(n=2)화경내동맥출혈(n=1)사망.위수술기적병발증솔위14.7%,사망솔위2.6%.94례환자수방6월~11년,36례발현종류복발혹원처전이,총복발급전이솔위38.5%.종류복발전이소치적사망솔위17.7%,악성종류복발전이적사망솔위23.2%.결론:대우로합면연합절제술응엄격파악기괄응증,주의종류근치화술후공능、생존솔화생존질량지간적평형,즉주중공능화외형、생존솔화생존질량、공구화수구、중요공능화차요공능지간적평형.
Objective:To review our patients who underwent cranio-maxillofacial resection in the recent 10 years and explore the indication of the operation. Methods:From 2003 to 2013, 116 patients underwent cranio-maxillofacial resection in our department for the treatment of tumors involving the skull base. Tumors that involved the skull base were divided into 3 types according to skull base invasions shown in the coronal planes of CT and MRI scans. Type 1 tumor was adjacent to the skull base with free bone (n=45), type 2 tumor involved the skull base with intact dura (n=30), and type 3 tumor involved dura with free brain (n=41). All patients underwent cranio-maxillofacial resection by oral and maxillofacial surgeons and neurosurgeons. The defects after cranio-maxillofacial resection were reconstructed immediately with adjacent local or regional flaps (n=62) and free vascularized flap (n=54) according to different de-fects, respectively. Results:Cranio-maxillofacial resection was successfully performed in all patients. No intraoperative complication was found. The overall success rate of soft tissue flaps and free flaps was 98.3%and 96.4%, respectively. Three patients with intracrani-al infection (n=2) and bleeding in the internal carotid artery were dead postoperatively even though they underwent salvage surgery. The overall rate of complications was 14.7%, and the dead rate was 2.6%. Recurrence or distant metastasis was found in 36 patients dur-ing the follow-up period. Conclusion: For the indication of cranio-maxillofacial resection, the balance between tumor resection and postoperative function, survival rate, and quality of life should always be considered. This technique includes the balance between func-tion and form, survival and quality of life, donor and recipient sites, and primary and secondary functions.